课题基金 / 基金详情

Cellular mechanisms of cardioprotection by ischemic preconditioning : Functional study using Kir6.2- (Kir6.2^<-/->) and Kir6.1-deficient (Kir6.1^<-/->) mice

Cellular mechanisms of cardioprotection by ischemic preconditioning : Functional study using Kir6.2- (Kir6.2^<-/->) and Kir6.1-deficient (Kir6.1^<-/->) mice
缺血预处理心脏保护的细胞机制:使用 Kir6.2- (Kir6.2^<-/->) 和 Kir6.1 缺陷 (Kir6.1^<-/->) 小鼠进行功能研究
批准号:
13670080
负责人:
NAKAYA Haruaki
金额:
$2.62万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

NAKAYA Haruaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In order to clarify the pathophysiological roles of sarcolemmal ATP-sensitive K^+ (sarcK_<ATP>) channel in cardiac and vascular smooth muscle cells, we conducted functional experiments using Kir6.2-deficient (Kir6.2^<-/->) and Kir6.1-deficient (Kir6.1^<-/->) mice.In ventricular cells of Kir6.2^<-/-> mice sarcK_<ATP> channel function was negated but the mitochondrial K_<ATP> (mitoK_<ATP>) channel function, evaluated by diazoxide-induced flavoprotein oxidation, was preserved. For ischemic preconditioning (IPC) experiments coronary artery was occluded for three periods of 3 min, each followed by 5 min reperfusion, before the long-term ischemia (45 min) in anesthetized mice. IPC reduced the infarct size in wild-type (WT) mice but not in Kir6.2^<-/-> mice. The recovery of the left ventricular contractile function after global ischemia/reperfusion was worse in Langendorff-perfused hearts of Kir6.2^<-/-> mice than in WT hearts. These findings indicate that sarcK_<ATP> channel is important for the establishment of ischemic preconditioning and the recovery of mechanical function after ischemia/reperfusion.We also evaluated sarcK_<ATP> channel function in cardiac and vascular smooth muscle cells of Kir6.1^<-/-> mice. Although both sarcK_<ATP> and mitoK_<ATP> channel function were preserved in cardiac cells of Kir6.1^<-/-> mice, functional responses of sarcK_<ATP> channels to K^+ channel openers were impaired in vascular smooth muscle cells of Kir6.1^<-/-> mice. Of particular interest are the findings that Kir6.2^<-/-> mice showed a high rate of sudden cardiac death associated with spontaneous ST elevation followed by atrioventricular block on ECG. These results suggest that Kir6.1 is critical in the regulation of vascular tone, especially in the coronary arteries, and the dysfunction of the K_<ATP> channel causes Prinzmetal angina.Thus, either Kir6.2 or Kir6.1 is absolutely important for the function of sarcK_<ATP> channels in the cardiovascular system.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
澤田康文: "薬物動態・作用と遺伝子多型 薬物治療の患者個別化を目指した21世紀の新展開"医薬ジャーナル社. 457 (2001)
Yasufumi Sawada:“药代动力学、作用和遗传多态性:21 世纪旨在实现患者个体化药物治疗的新发展”Iyaku Journal Inc. 457 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
中谷晴昭: "抗不整脈薬の薬理学 -分子レベルの作用-"分子心血管病. 3. 41-47 (2002)
Haruaki Nakatani:“抗心律失常药物的药理学 - 分子水平效应 -”分子心血管疾病。 3. 41-47 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
中谷晴昭: "看護に役立つ薬理学の視点"看護. 54. 044-047 (2002)
Haruaki Nakatani:“对护理有用的药理学观点”护理 54. 044-047 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
中谷晴昭: "薬剤誘発性QT延長症候群と創薬"治療学. 35. 24-24 (2001)
Haruaki Nakatani:“药物引起的长 QT 综合征和药物发现”《治疗学》35. 24-24 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Assessment of role of Kir6.1 subunit (ATP-sensitive K+ channel) in J wave syndrome
    • 批准号:
      26460334
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2014
    • 负责人:
      NAKAYA Haruaki
    • 依托单位:
    Functional role of ATP-sensitive K^+ channel in vascular endothelial cells
    • 批准号:
      20590249
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2008
    • 负责人:
      NAKAYA Haruaki
    • 依托单位:
    Molecular and functional analysis of ATP-sensitive K^+ channel on the nuclear envelope
    • 批准号:
      18590232
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.57万
    • 财政年份:
      2006
    • 负责人:
      NAKAYA Haruaki
    • 依托单位:
    Role of Kir6.1 channels in cardiomyocytes clarified by Kir6.1-transgenic mice
    • 批准号:
      15390078
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      2003
    • 负责人:
      NAKAYA Haruaki
    • 依托单位:
    海外基金